NANOG and acute myeloid leukemia: Analysis of dataset GSE61804 which contains 325 AML samples with normal and abnormal karyotypes indicated equally infrequent NANOG-overexpressing patients (11/325, 3.4%), unrelated to particular chromosomal aberrations thus excluding subtype-specific activity (S5 Fig).